So fortunate to start my career as a GI oncologist at the institution where my medical training began Lewis Katz School of Medicine Fox Chase Cancer Center

"Current research suggests early-onset GI cancers may be influenced by changes in bacterial species of gut microbiome, early antibiotic exposure or environmental carcinogens." says Chris Cann, MD in a Yahoo article on rising cancer rates in those under 50: yhoo.it/3KIp6Re

Fox Chase Cancer Center Welcomes Dr. Christopher G. Cann Chris Cann, MD Fox Chase Cancer Center #medtwitter ow.ly/2LRX50PCoar

Great work validating a regression score to better predict pathological response, William A Hall, MD . Excited to apply this in our #NEO-RT phase III trial of STAGE I #rectalcancer. Dr. Carl J Brown 🌎 NCI CTEP Clinical Research Chris Cann, MD Mark Whiteford Val Simianu

GREAT evening catching up with my @ecog NCI CTEP Clinical Research colleagues from Fox Chase Cancer Center Penn Medicine - Abramson Cancer Center Vanderbilt-Ingram Cancer Center and learning about new #CancerResearch concepts. We all have 1️⃣ 🎯 #curing #cancer. Kristen Ciombor Laura Goff Efrat Dotan MD Michael Gibson, MD PhD Vanderbilt University. Chris Cann, MD

Combined Hepatic Arterial Infusion Pump and Systemic Chemotherapy in the Modern Era for Chemo Naive Patients with Unresectable Colorectal Liver Metastases ⁦AnnalsSurgOncology⁩ ⁦SSAT⁩ ⁦⁩ ⁦Michael Lidsky, MD, FACS⁩ ⁦Lee M. Ocuin MD, FACS⁩ link.springer.com/article/10.124…

Our Phase III CO.32 NEO-RT trial is finalized and will open next month. Stoked to meet up with study champs and team at #GI24. Please check your NCTN menu to activate when ready. ⁦CCTG⁩ ⁦Chris Cann, MD⁩ ⁦Noam VanderWalde⁩ ⁦⁦Dr. Carl J Brown 🌎⁩ ⁦

The Vanderbilt-Ingram Cancer Center team #dimsum pregamed to support our Division Chief Dr. jordan berlin for his 🤩👏🏻PHENOMENAL discussion yesterday @asco #GI24 with 2 former Vanderbilt University Medical Center fellows Chris Cann, MD Marc Roth. Kristen Ciombor Rajiv Agarwal MD Brian Grieb MD, PhD Dana Cardin, MD #Cancer

Even if you’re young, colorectal cancer should be on your radar. Fox Chase's Dr. Chris Cann, MD shares with SELF that if you're dealing with digestive symptoms and they seem to drag on, or they just feel off, it’s “imperative” to speak to a doctor: self.com/story/how-to-p…

Toby Keith's death has raised a lot of questions about stomach cancer, including who it typically affects and how it's treated. Dr. Christopher Cann (Chris Cann, MD), of Fox Chase Cancer Center, shares important information on stomach cancer with Yahoo News: yhoo.it/491vxcn

So delighted to see our current and former Vanderbilt University Medical Center Vanderbilt-Ingram Cancer Center fellows come back for a visit!! Chris Cann, MD now at Fox Chase Cancer Center ✈️ in for the Colon Cancer Foundation #EAOCRC Summit!!! Vanderbilt Health Kathy Walsh, MD, MAEd #CancerResearch #crcsm #cancer

Woohoo! #NEO-RT Trial activated ahead of schedule and ready to open! Thanks to all of the support! Dr. Carl J Brown 🌎 CCTG NCI CTEP Clinical Research Josh Smith, MD, PhD, FACS Mark Whiteford Sharlene Gill, MD, MPH, MBA, FASCO Dr. Cathy Eng Karyn Goodman, MD, MS Jonathan Loree A quick Xtorial: 1/10

⭐️THRILLED to host this meeting w/ my good friend Dr. Cathy Eng in beautiful Nashville. Join us as we have the LEADING thought leaders discuss the latest data including a special appearance by the Oncology Brothers Register here👇 web.cvent.com/event/c61fd6dd… Dr. Cathy Eng David R. Spigel, MD, FASCO

🤩Efrat Dotan MD presents NCI CTEP Clinical Research @EAOnc EA2186: Randomized Phase II Gem/Nab-Paclitaxel vs. 5-FU/LV/ Liposomal Irinotecan in Older Pts with Tx-Naive Met Pancreatic Cancer (GIANT) #asco24 ASCO #cancer #cancerresearch noted NS difference in OS but demonstrates the imp of

Thanks so much for the opportunity The Fellow On Call! You continue to do amazing work for the heme/onc community

🙏💪💙 to co-authors Drs. Yoshino, Ruíz-García, Nermean Chris Cann, MD Perez, Cremolini and research coordinators: B O’Brian, A Benny in creating an INT'L perspective on #colorectalcancer #cancer #cancerreserch doi.org/10.1016/S0140-… The Lancet